Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pegvisomant or pasirotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.
Araujo-Castro M, Biagetti B, Menedez-Torre E, Novoa-Testa I, Cordido F, Pascual-Corrales E, Rodríguez Berrocal V, Guerrero-Pérez F, Vicente A, Percovich Hualpa JC, Garcia Centeno R, González Fernández L, Ollero García MD, Irigaray Echarri A, Moure Rodríguez MD, Novo-Rodríguez C, Calatayud M, Villar R, Bernabéu I, Alvarez-Escola C, Benítez Valderrama P, Tenorio C, Abellán Galiana P, Venegas E, González-Molero I, Iglesias P, Blanco-Carrera C, Vidal-Ostos De Lara F, de Miguel Novoa P, López Mezquita E, Hanzu FA, Aldecoa I, Aznar S, Lamas C, Aulinas A, Queralt Asla A, Gracia Gimeno P, Recio Córdova JM, Aviles M, Asensio-Wandosel D, Sampedro-Núñez M, Camara R, Paja Fano M, Ruz-Caracuel I, Fajardo C, Marazuela M, Puig-Domingo M. Araujo-Castro M, et al. Among authors: venegas e. Endocr Relat Cancer. 2024 May 1:ERC-24-0043. doi: 10.1530/ERC-24-0043. Online ahead of print. Endocr Relat Cancer. 2024. PMID: 38713182
Integrative Clinical, Hormonal and Molecular Data associate with Invasiveness in Acromegaly: REMAH Study.
Sampedro-Nuñez M, Herrera-Martínez AD, Ibáñez-Costa A, Rivero-Cortés E, Venegas E, Robledo M, Martínez-Hernández R, García-Martínez A, Gil J, Jordà M, López-Fernández J, Gavilán I, Maraver S, Marqués-Pamies M, Cámara R, Fajardo-Montañana C, Valassi E, Dios E, Aulinas A, Biagetti B, Álvarez Escola C, Araujo-Castro M, Blanco C, de Miguel P, Villar-Taibo R, Álvarez CV, Gaztambide S, Webb SM, Castaño L, Bernabéu I, Picó A, Gálvez MÁ, Soto-Moreno A, Puig-Domingo M, Castaño JP, Marazuela M, Luque RM; REMAH investigators. Sampedro-Nuñez M, et al. Among authors: venegas e. Eur J Endocrinol. 2024 May 3:lvae045. doi: 10.1093/ejendo/lvae045. Online ahead of print. Eur J Endocrinol. 2024. PMID: 38701338
Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly.
Ruiz S, Gil J, Biagetti B, Venegas E, Cámara R, Garcia-Centeno R, Gálvez MÁ, Picó A, Maraver S, González I, Abellán P, Trincado P, Herrera M, Olvera P, Xifra G, Bernabeu I, Serra-Soler G, Azriel S, García L, Carvalho D, Jordà M, Valassi E, Puig J, Puig-Domingo M. Ruiz S, et al. Among authors: venegas e. Clin Endocrinol (Oxf). 2023 Oct;99(4):378-385. doi: 10.1111/cen.14946. Epub 2023 Jul 8. Clin Endocrinol (Oxf). 2023. PMID: 37421211
Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly.
Bernabéu I, Fajardo C, Marazuela M, Cordido F, Venegas EM, de Pablos-Velasco P, Maroto GP, Olvera MP, de Paz IP, Carvalho D, Romero C, De la Cruz G, Escolá CÁ. Bernabéu I, et al. Among authors: venegas em. Endocrine. 2020 Dec;70(3):575-583. doi: 10.1007/s12020-020-02424-z. Epub 2020 Jul 28. Endocrine. 2020. PMID: 32725444 Free PMC article.
Diagnosis, treatment and follow-up of patients with acromegaly in a clinical practice setting in Spain: the ACROPRAXIS program Delphi survey.
de Pablos-Velasco P, Venegas EM, Álvarez Escolá C, Fajardo C, de Miguel P, González N, Bernabéu I, Valdés N, Paja M, Díez JJ, Biagetti B. de Pablos-Velasco P, et al. Among authors: venegas em. Pituitary. 2020 Apr;23(2):129-139. doi: 10.1007/s11102-019-01012-3. Pituitary. 2020. PMID: 31823249 Free PMC article.
45 results